Nasdaq · Healthcare
TRIMBLE INC. (TRMB)
As-reported financials and recent SEC filings for TRIMBLE INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$3.59B
Net income
$424.0M
Net margin
11.8%
Diluted EPS
$1.76
ROE
7.3%
P/E (TTM)
26.5×
Market cap
$11.82B
Debt / equity
0.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.59B | $3.68B | $3.80B | $3.68B | $3.66B |
| Gross profit | $2.48B | $2.40B | $2.33B | $2.11B | $2.03B |
| Operating income | $592.0M | $460.7M | $448.8M | $510.9M | $561.0M |
| Net income | $424.0M | $1.50B | $311.3M | $449.7M | $492.7M |
| Diluted EPS | $1.76 | $6.09 | $1.25 | $1.80 | $1.94 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-05-28
View on EDGAR →Go deeper on TRMB
Search TRIMBLE INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.